Your browser doesn't support javascript.
loading
Multidimensional Molecular Profiling of Metastatic Triple-Negative Breast Cancer and Immune Checkpoint Inhibitor Benefit.
Barroso-Sousa, Romualdo; Forman, Juliet; Collier, Katharine; Weber, Zachary T; Jammihal, Tejas R; Kao, Katrina Z; Richardson, Edward T; Keenan, Tanya; Cohen, Ofir; Manos, Michael P; Brennick, Ryan C; Ott, Patrick A; Hodi, F Stephen; Dillon, Deborah A; Attaya, Victoria; O'Meara, Tess; Lin, Nancy U; Van Allen, Eliezer M; Rodig, Scott; Winer, Eric P; Mittendorf, Elizabeth A; Wu, Catherine J; Wagle, Nikhil; Stover, Daniel G; Shukla, Sachet A; Tolaney, Sara M.
Afiliación
  • Barroso-Sousa R; Oncology Center, Hospital Sírio-Libanês, Brasília, Brazil.
  • Forman J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Collier K; Broad Institute of MIT and Harvard, Cambridge, MA.
  • Weber ZT; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA.
  • Jammihal TR; Ohio State University College of Medicine, Columbus, OH.
  • Kao KZ; Ohio State University College of Medicine, Columbus, OH.
  • Richardson ET; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Keenan T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Cohen O; Department of Pathology, Brigham and Women's Hospital, Boston, MA.
  • Manos MP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Brennick RC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Ott PA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Hodi FS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Dillon DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Attaya V; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • O'Meara T; Department of Pathology, Brigham and Women's Hospital, Boston, MA.
  • Lin NU; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Van Allen EM; Internal Medicine, Brigham and Women's Hospital, Boston, MA.
  • Rodig S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Winer EP; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.
  • Mittendorf EA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Wu CJ; Department of Pathology, Brigham and Women's Hospital, Boston, MA.
  • Wagle N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Stover DG; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.
  • Shukla SA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.
  • Tolaney SM; Divison of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA.
JCO Precis Oncol ; 6: e2100413, 2022 07.
Article en En | MEDLINE | ID: mdl-35797509
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Triple Negativas Límite: Humans Idioma: En Revista: JCO Precis Oncol Año: 2022 Tipo del documento: Article País de afiliación: Brasil Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Triple Negativas Límite: Humans Idioma: En Revista: JCO Precis Oncol Año: 2022 Tipo del documento: Article País de afiliación: Brasil Pais de publicación: Estados Unidos